ENOV vs ALMR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ENOV · Enovis Corp$27.16 ▼ 5.10%
ALMR · Alamar Biosciences$28.05 ▲ 4.26%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ENOV +3.2%
- ALMR +27.5%
Head to head
| Metric | ENOV | ALMR |
|---|---|---|
| Price | $27.16 | $28.05 |
| Change today | ▼ 5.10% | ▲ 4.26% |
| Market cap | $1.57B | $1.95B |
| Return, 3 months | +12.0% | +0.2% |
| Return, year to date | +2.0% | – |
| Return, 1 year | -3.2% | – |
| P/E (TTM) | – | – |
| P/B | 1.0 | 6.4 |
| P/E percentile vs own 5y | 69th | 43rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.2% | +82.1% |
| Net profit growth (YoY) | +97.2% | -87.9% |
| Gross margin | 61.1% | 58.7% |
| Operating margin | 3.1% | -40.6% |
| Net margin | -48.0% | -49.5% |
| Return on equity | -54.3% | -15.9% |
| Analyst target vs. price | +33.3% | +16.5% |
| Analyst buy share | 91% | 67% |
| RSI (14) | 69 | 46 |
| 30-day volatility | 85.4% | 115.2% |
| Max drawdown, 1 year | -47.0% | -38.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ALMR is the largest of the group by market value.
- ALMR is growing revenue fastest.
- ENOV keeps the most profit per dollar of sales.
- ENOV has been the calmest stock over the last 30 days.